SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: M. LaMancha who wrote (72)12/16/1996 11:46:00 AM
From: Christopher Moylen   of 371
 
Your Welcome. As an investor of IMMU, I am very optimistic with regards to the performance of the stock. However, I have not invested in this company on a hunch. I have been following IMMU for a very long time and have done extensive research into the company's credibility and product line. The company is located in Morris Plains, NJ. Their facilities are very impressive. This company is very serious about their research and development, with many products in the testing phase.
In my opinion, the stock is a bargain around 6 dollars. Their are biotech company's on the market that do not even have FDA approval of their products, or solid financial strength. These company's are trading at prices three times that of IMMU.
IMMU has nowhere to go but up! Look for positive news to come out in the next few weeks. Then, watch for the earnings report in January to produce a positive surge in the stock price. I don't see the stock hanging around 6 dollars too much longer after the rest of Wall Street catches on. IMMU- a future star of Nasdaq.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News